Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 20;4(12):e128432.
doi: 10.1172/jci.insight.128432.

Clones of infected cells arise early in HIV-infected individuals

Affiliations

Clones of infected cells arise early in HIV-infected individuals

John M Coffin et al. JCI Insight. .

Abstract

In HIV-infected individuals on long-term antiretroviral therapy (ART), more than 40% of the infected cells are in clones. Although most HIV proviruses present in individuals on long-term ART are defective, including those in clonally expanded cells, there is increasing evidence that clones carrying replication-competent proviruses are common in patients on long-term ART and form part of the HIV reservoir that makes it impossible to cure HIV infection with current ART alone. Given the importance of clonal expansion in HIV persistence, we determined how soon after HIV acquisition infected clones can grow large enough to be detected (clones larger than ca. 1 × 105 cells). We studied 12 individuals sampled in early HIV infection (Fiebig stage III-V/VI) and 5 who were chronically infected. The recently infected individuals were started on ART at or near the time of diagnosis. We isolated more than 6,500 independent integration sites from peripheral blood mononuclear cells before ART was initiated and after 0.5-18 years of suppressive ART. Some infected clones could be detected approximately 4 weeks after HIV infection and some of these clones persisted for years. The results help to explain how the reservoir is established early and persists for years.

Keywords: AIDS/HIV; Clonal selection; T cells.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: JWM is a consultant to Gilead Sciences and Merck Co., Inc., and owns share options in Co-Crystal Pharmaceuticals, Inc. JJE is a consultant to Merck Co, Inc., Janssen Pharmaceuticals, Gilead Sciences, and ViiV Healthcare.

Figures

Figure 1
Figure 1. Summary of the results for all of the donors in Tables 2–5.
(A and B) The plots show the individual pre-ART (blue circles) and on-ART (orange squares) data, which were obtained from donors who were diagnosed and put on ART in Fiebig stage III–IV (group 1a), Fiebig stage IV/V–V (group 1b), Fiebig stages V/VI–VI (group 2), or were chronically infected at the time treatment was initiated. (A) Total HIV DNA per million PBMCs. (B) Integration sites recovered per million PBMCs. (C) Frequency of all integration sites with more than 1 breakpoint (green circles) or in confirmed clones (purple circles). Orange squares in C indicate frequency of clones in the on-ART PBMC samples from the same donors. Open symbols denote samples with no integrations in clones or with more than 1 breakpoint, plotted at the limit of detection (1/number of sites in all samples). Horizontal bars show the ratio for each group as a whole. The open purple bar in the Fiebig III–IV group, which had no confirmed clones, indicates the limit of detection of clones for the group as a whole.
Figure 2
Figure 2. Neighbor-joining trees of P6-PR-RT single-genome sequences.
Single proviral sequences were obtained from pre-ART and on-ART PBMCs collected from donors who were fully suppressed for the duration of the study (no blips and no treatment interruptions). Neighbor-joining trees were inferred using MEGA, with the consensus subtype B HIV sequence as an outgroup. Pre-ART proviral sequences are shown in open triangles and on-ART proviral sequences in closed triangles. Sequences with long branches due to G to A hypermutations, which are formed at the time of infection and found in all patients, are not shown, but the numbers of hypermutant sequences found at both time points are shown above each tree. PID, patient identifier; APD, average pairwise distance.

References

    1. Lorenzo-Redondo R, et al. Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature. 2016;530(7588):51–56. doi: 10.1038/nature16933. - DOI - PMC - PubMed
    1. Kearney MF, et al. Ongoing HIV replication during ART reconsidered. Open Forum Infect Dis. 2017;4(3):ofx173. - PMC - PubMed
    1. Hosmane NN, et al. Proliferation of latently infected CD4(+) T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics. J Exp Med. 2017;214(4):959–972. doi: 10.1084/jem.20170193. - DOI - PMC - PubMed
    1. Dinoso JB, et al. Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 2009;106(23):9403–9408. doi: 10.1073/pnas.0903107106. - DOI - PMC - PubMed
    1. Kearney MF, et al. Well-mixed plasma and tissue viral populations in RT-SHIV-infected macaques implies a lack of viral replication in the tissues during antiretroviral therapy. Retrovirology. 2015;12:93. - PMC - PubMed

Publication types

Substances